Trial · NCT02534038
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline in the Disinhibition Domain of the Neuropsychiatric Inventory (NPI) | Baseline; Week 6, Week 8, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the Total NPI Score | Baseline; Week 6, Week 8, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the NPI Total Caregiver Distress | Baseline; Week 6, Week 8, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the NPI Disinhibition Domain Caregiver Distress | Baseline; Week 1, Week 3, Week 6, Week 8, Week 9, Week 11, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the Frontal Behavioral Inventory (FBI) Total Score | Baseline; Week 1, Week 3, Week 6, Week 8, Week 9, Week 11, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the FBI Disinhibition Domain Score | Baseline; Week 1, Week 3, Week 6, Week 9, Week 11, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From the First Assessment for the Modified Clinical Global Impression of Change (mCGIC) Scale | Week 3, Week 6, Week 11, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From the First Assessment for the Patient Global Impression of Change (PGIC) Scale | Week 3, Week 6, Week 11, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the Quality of Relationships (QoR) Scale | Baseline; Week 6, Week 8, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the Quality of Life (QoL) Scale | Baseline; Week 6, Week 8, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the Interpersonal Reactivity Index (IRI) | Baseline; Week 6, Week 8, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the Center for Neurologic Study-Lability Scale (CNS-LS) | Baseline; Week 6, Week 8, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the Mini-Mental State Examination (MMSE) | Baseline; Week 6, Week 8, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the Cornell Scale for Depression in Dementia (CSDD) | Baseline; Week 6, Week 8, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. | ||
| SECONDARY | Change From Baseline for the Stroop Color and Word Task | Baseline; Week 6, Week 8, and Week 14 | No efficacy analyses were conducted due to the limited number of participants enrolled prior to study termination (N=1). In order to protect the privacy of participants, the results of enrolled participants cannot be reported. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02534038/outcomes